See All Slides - tctmd.com

Slides

Presentation ECHO 2017

Chamber Quantification Guidalines Update Left: Heart Measurements

Presenter: Rebecca T. Hahn

March 31, 2017

Presentation ECHO 2017

ASE Guidelines for 3D Adquisition and Imaging

Presenter: Rebecca T. Hahn

March 31, 2017

Presentation ACC 2017

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS

Presenter: Magnus Ohman

March 27, 2017

Presentation CHIP Washington DC 2017

A Brief Update of PCI for Left Main Disease: Perspectives After the EXCEL and NOBLE Trials

Presenter: Gregg W. Stone

March 21, 2017

Presentation CHIP Washington DC 2017

Case Presentation: Calcium and Atherectomy

Presenter: Manish A. Parikh

March 21, 2017

Presentation ACC 2017

Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

Presenter: Michael Mack

March 20, 2017

Presentation ACC 2017

iFR vs FFR-guided Coronary Intervention – iFR-SWEDEHEART

Presenter: Matthias Götberg

March 20, 2017

Presentation ACC 2017

Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis

Presenter: Stephen J Nicholls

March 20, 2017

Presentation ACC 2017

EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Presenter: Jeff Weitz

March 20, 2017

Presentation ACC 2017

DECISION-CTO: Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion

Presenter: Seung-Jung Park

March 20, 2017

Advertisement

Slides

Chamber Quantification Guidalines Update Left: Heart Measurements

ASE Guidelines for 3D Adquisition and Imaging

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS

A Brief Update of PCI for Left Main Disease: Perspectives After the EXCEL and NOBLE Trials

Case Presentation: Calcium and Atherectomy

Cerebral Embolic Protection In Patients Undergoing Surgical Aortic Valve Replacement (SAVR)

iFR vs FFR-guided Coronary Intervention – iFR-SWEDEHEART

Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis

EINSTEIN CHOICE: Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

DECISION-CTO: Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content